Essentia Health launches new Alzheimer’s detection test 

The test detects amyloid plaques, abnormal brain protein deposits linked to cognitive impairment and a key indicator of Alzheimer's.

Essentia Health has introduced a new diagnostic test for the early detection of Alzheimer’s disease at its downtown Duluth campus in Minnesota, US.

According to the company, this condition currently affects more than seven million individuals in the country.

The test identifies amyloid plaques, which are abnormal protein deposits in the brain associated with cognitive impairment and are a key indicator of Alzheimer’s.

Sign up for Blog Updates